Eastin Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -6.99%
- Ebitda -6.99%
- Net Worth -3.45%
- Total Assets 43.04%
About Eastin Diagnostics
Eastin Diagnostics Private Limited (EDPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 September 2021 (Three years and five months 6 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Prashant Gomkale, Jitendra Bagal, and Gahineenath Rahade serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85100PN2021PTC204136
-
Company No.
204136
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Sep 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Eastin Diagnostics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prashant Gomkale
|
Director | 09-Sep-2021 | Current |
|
Jitendra Bagal
|
Director | 09-Sep-2021 | Current |
|
Gahineenath Rahade
|
Director | 09-Sep-2021 | Current |
Financial Performance of Eastin Diagnostics.
Eastin Diagnostics Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 6.99% decrease in profit. The company's net worth dipped by a decrease of 3.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eastin Diagnostics?
Unlock access to Eastin Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Nucmed Pharma LlpPrashant Gomkale is a mutual person
-
Herkules Pharmaceuticals Private Limited
Prashant Gomkale and Jitendra Bagal are mutual person
-
Nucleus Medisurge Private Limited
Prashant Gomkale is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eastin Diagnostics?
Eastin Diagnostics has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eastin Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eastin Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.